# Eurofins Lancaster Laboratories, Inc – FDA Inspection, May 6, 2011

Source: https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/9e056c66-572d-4816-ba9f-ca1de618a628
Source feed: FDA_Inspections

> FDA inspection 724139 of Eurofins Lancaster Laboratories, Inc, May 06, 2011. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 724139
- Company Name: Eurofins Lancaster Laboratories, Inc
- Inspection Date: 2011-05-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1272016 - 2025-05-30](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/303e9119-e97b-46ac-953b-55ee592c5e2e)
- FDA Inspection 1160560 - 2021-12-10
- FDA Inspection 1080439 - 2019-01-23
- FDA Inspection 1045298 - 2018-02-23
- [FDA Inspection 1001348 - 2016-11-04](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/19955c49-0273-4c87-b3d7-7aa5f1cbf109)

Company: https://www.keypedia.com/companies/eurofins-lancaster-laboratories-inc/a5676b12-3275-4a99-8f4b-3877e1728255

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c